Hughes D - Search Results

1

Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.

Mahajan A, Woo SY, Kornguth DG, Hughes D, Huh W, Chang EL, Herzog CE, Pelloski CE, Anderson P. Mahajan A, et al. Among authors: hughes d. Pediatr Blood Cancer. 2008 May;50(5):976-82. doi: 10.1002/pbc.21451. Pediatr Blood Cancer. 2008. PMID: 18213710

2

Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma).

Anderson P, Kopp L, Anderson N, Cornelius K, Herzog C, Hughes D, Huh W. Anderson P, et al. Among authors: hughes d. Expert Opin Investig Drugs. 2008 Nov;17(11):1703-15. doi: 10.1517/13543784.17.11.1703. Expert Opin Investig Drugs. 2008. PMID: 18922107 Review.

3

Complications in the surgical treatment of pediatric melanoma.

Palmer PE 3rd, Warneke CL, Hayes-Jordan AA, Herzog CE, Hughes DP, Lally KP, Austin MT. Palmer PE 3rd, et al. J Pediatr Surg. 2013 Jun;48(6):1249-53. doi: 10.1016/j.jpedsurg.2013.03.018. J Pediatr Surg. 2013. PMID: 23845614

4

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.

Guma SR, Lee DA, Yu L, Gordon N, Hughes D, Stewart J, Wang WL, Kleinerman ES. Guma SR, et al. Among authors: hughes d. Pediatr Blood Cancer. 2014 Apr;61(4):618-26. doi: 10.1002/pbc.24801. Epub 2013 Oct 18. Pediatr Blood Cancer. 2014. PMID: 24136885 Free PMC article.

5

Effect of concurrent metastatic disease on survival in children and adolescents undergoing lung resection for metastatic osteosarcoma.

Slade AD, Warneke CL, Hughes DP, Lally PA, Lally KP, Hayes-Jordan AA, Austin MT. Slade AD, et al. Among authors: hughes dp. J Pediatr Surg. 2015 Jan;50(1):157-60; discussion 160. doi: 10.1016/j.jpedsurg.2014.10.038. Epub 2014 Oct 28. J Pediatr Surg. 2015. PMID: 25598115

6

Cardiovascular involvement by osteosarcoma: an analysis of 20 patients.

Yedururi S, Morani AC, Gladish GW, Vallabhaneni S, Anderson PM, Hughes D, Wang WL, Daw NC. Yedururi S, et al. Among authors: hughes d. Pediatr Radiol. 2016 Jan;46(1):21-33. doi: 10.1007/s00247-015-3449-y. Epub 2015 Sep 28. Pediatr Radiol. 2016. PMID: 26411434 Free PMC article.

7

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition.

Hughes DP, Thomas DG, Giordano TJ, McDonagh KT, Baker LH. Hughes DP, et al. Pediatr Blood Cancer. 2006 May 1;46(5):614-23. doi: 10.1002/pbc.20454. Pediatr Blood Cancer. 2006. PMID: 16007579 Free article.

8

Strategies for the targeted delivery of therapeutics for osteosarcoma.

Hughes DP. Hughes DP. Expert Opin Drug Deliv. 2009 Dec;6(12):1311-21. doi: 10.1517/17425240903280422. Expert Opin Drug Deliv. 2009. PMID: 19761419 Free PMC article. Review.

9

miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES. Huang G, et al. Among authors: hughes d. Cancer Res. 2012 Feb 15;72(4):908-16. doi: 10.1158/0008-5472.CAN-11-1460. Epub 2011 Dec 20. Cancer Res. 2012. PMID: 22186140 Free PMC article.

10

How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.

Hughes DP. Hughes DP. Cancer Treat Res. 2009;152:479-96. doi: 10.1007/978-1-4419-0284-9_28. Cancer Treat Res. 2009. PMID: 20213410 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,974 results

Search Page

Filters